Adjuvantz Adopts Symbility Health’s Claims Connect Platform

Toronto, ON (Dec. 16, 2014) – Symbility Health Inc., a division of Symbility Solutions Inc., a global provider of cloud-based and smartphone/tablet-enabled claims technology for the property and casualty and health insurance industries, is pleased to announce that it has signed a contract with Adjuvantz, a leading Canadian healthcare organization offering medical support solutions to the pharmaceutical, biotechnology and insurance industries.

Adjuvantz will implement Symbility Health’s Claims Connect® technology to manage their medical support programs and allow for a more effective and seamless collaboration between program managers, patients, insurance payers, and prescription drug fulfillment providers. Thanks to Symbility Health’s Claims Connect platform, Adjuvantz’ new business rule-driven system will function with greater speed and efficiency, creating a more intuitive workflow for Adjuvantz’s users, including:

  • Quicker patient profile management, ensuring that required actions and tasks within a patient’s profile are optimally actioned.
  • Ability to access Symbility Health’s ecosystem of carriers, third-party administrators, patients, pharmacy benefit management and specialty pharmacy fulfillment.
  • Customization potential of Symbility Health’s adjudication technology will enable Adjuvantz to build tailor-made features and functionalities to adapt their product offering to the evolving health claims industry and ultimately reach new geographic areas.

This contract also represents the next link in the healthcare ecosystem by allowing Adjuvantz to integrate seamlessly with specialty pharmacies, such as BioScript Pharmacy, in order to fulfill scripts and deliver drug infusions.

“We are very excited to be working with Symbility. This partnership will create a technology solution head and shoulders above anything else available in the market today.” Jay Mayers, Head of Adjuvantz.

“By working with Adjuvantz, Symbility Health has brought a key participant in the prescription drug landscape into our collaborative ecosystem,” commented Richard Adair, CEO, Symbility Health. “We look forward to increasing the positive effect that our technology can have on the healthcare delivered through Adjuvantz’s programs.”

About Adjuvantz

Adjuvantz is a Canadian provider of therapeutic medical support solutions. Following a clinically designed foundation, Adjuvantz’ mandate is the provision of access support and improved health outcomes.

With a comprehensive understanding of industry access and care issues, Adjuvantz develops innovative medical solutions customized to meet the unique needs of its clients. Adjuvantz programs recognise and build upon the need to keep in touch with patients and health care professionals, assist with choices and provide current and valid information. Learn more at

About Symbility Solutions Inc.

Symbility Solutions® (TSX Venture: SY) is a global provider of cloud-based and smartphone/tablet-enabled claims technology for the property and health insurance industries. Designed to be flexible and easy-to-use, Symbility Solutions’ two product suites, Symbility Property™ and Symbility Health™, empower insurers to collaborate across the entire claims processing workflow and reduce costs while delivering a market-leading claims experience. For more information, please visit

Forward-Looking Information

Except for historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements represent the Symbility’s best judgment based on information currently available. Actual results are subject to various known and unknown risks and uncertainties, many of which are beyond the ability of Symbility Solutions to control or predict and, as a result, the actual results may differ materially from those expressed or implied in the forward-looking statements. Symbility Solutions Inc. will not update these forward-looking statements to reflect events or circumstances after the date hereof. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. More detailed information about potential factors that could affect financial results is included in the documents filed from time to time with the Canadian securities regulatory authorities by Symbility Solutions Inc.

All trade names are the property of their respective owners.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Source: Symbility Solutions Inc.

Tags: ,